These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25562996)

  • 1. Urease production as a marker of virulence in Pseudomonas aeruginosa.
    Bradbury RS; Reid DW; Champion AC
    Br J Biomed Sci; 2014; 71(4):175-7. PubMed ID: 25562996
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of glycerol-3-phosphate dehydrogenase on virulence factor production by Pseudomonas aeruginosa.
    Daniels JB; Scoffield J; Woolnough JL; Silo-Suh L
    Can J Microbiol; 2014 Dec; 60(12):857-63. PubMed ID: 25409940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis.
    Fegan M; Francis P; Hayward AC; Davis GH; Fuerst JA
    J Clin Microbiol; 1990 Jun; 28(6):1143-6. PubMed ID: 2116444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors.
    Deretic V; Schurr MJ; Boucher JC; Martin DW
    J Bacteriol; 1994 May; 176(10):2773-80. PubMed ID: 8188579
    [No Abstract]   [Full Text] [Related]  

  • 5. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist.
    Lyczak JB; Cannon CL; Pier GB
    Microbes Infect; 2000 Jul; 2(9):1051-60. PubMed ID: 10967285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alginate, elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites].
    Ciragil P; Söyletir G
    Mikrobiyol Bul; 2004 Oct; 38(4):341-7. PubMed ID: 15700659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of D-amino acid dehydrogenase on virulence factor production by a Pseudomonas aeruginosa.
    Oliver KE; Silo-Suh L
    Can J Microbiol; 2013 Sep; 59(9):598-603. PubMed ID: 24011342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 9. Colonisation of cystic fibrosis patients by non-mucoid Pseudomonas aeruginosa--characterisation of the alginate from mucoid variants.
    Tatnell PJ; Russell NJ; Govan JR; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):406S. PubMed ID: 8878950
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Döring G; Obernesser HJ; Botzenhart K; Flehmig B; Høiby N; Hofmann A
    J Infect Dis; 1983 Apr; 147(4):744-50. PubMed ID: 6404993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic therapy against Pseudomonas aeruginosa and other gram-negative bacteria in cystic fibrosis].
    Le Bourgeois M
    Arch Pediatr; 2003 Sep; 10 Suppl 2():352s-357s. PubMed ID: 14671934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Høiby N; Espersen F; Koch C
    Thorax; 1992 Jan; 47(1):6-13. PubMed ID: 1539148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host response to Pseudomonas aeruginosa.
    Döring G
    Acta Paediatr Scand Suppl; 1989; 363():37-9; discussion 40. PubMed ID: 2518396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung infections. 3. Pseudomonas aeruginosa and other related species.
    Wilson R; Dowling RB
    Thorax; 1998 Mar; 53(3):213-9. PubMed ID: 9659359
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of pyocyanin in Pseudomonas aeruginosa infection.
    Lau GW; Hassett DJ; Ran H; Kong F
    Trends Mol Med; 2004 Dec; 10(12):599-606. PubMed ID: 15567330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
    Hubert D; Desmazes-Dufeu N; Dusser D
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular detection of virulence genes in Pseudomonas aeruginosa isolated from children with Cystic Fibrosis and burn wounds in Iran.
    Faraji F; Mahzounieh M; Ebrahimi A; Fallah F; Teymournejad O; Lajevardi B
    Microb Pathog; 2016 Oct; 99():1-4. PubMed ID: 27457974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N; Ciofu O; Bjarnsholt T
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of quorum-sensing-dependent virulence factors and biofilm formation of clinical and environmental Pseudomonas aeruginosa strains by ZnO nanoparticles.
    García-Lara B; Saucedo-Mora MÁ; Roldán-Sánchez JA; Pérez-Eretza B; Ramasamy M; Lee J; Coria-Jimenez R; Tapia M; Varela-Guerrero V; García-Contreras R
    Lett Appl Microbiol; 2015 Sep; 61(3):299-305. PubMed ID: 26084709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis.
    Geddes DM
    Lancet; 2001 Aug; 358(9281):522-3. PubMed ID: 11520516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.